Total Positions
75
Quarter
2024 Q3
Top Holding
XBI (9.0%)
Top 10 Concentration
42.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 75
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
XBI
PUT
SPDR SER TR
|
PUT Option | 8.95% | — |
#1
Prev: #—
|
5.6 | 300,000 | no change |
NEW
|
300,000 | $29,640,000 | 2015 Q1 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
N/A
BIOHAVEN LTD
|
—
|
Unknown | 5.26% | — |
#2
Prev: #—
|
4.1 | 348,778 | no change |
NEW
|
348,778 | $17,428,437 | — | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | ||
|
SRPT
SAREPTA THERAPE...
|
Healthcare | 4.53% | 2.72% |
#3
10
Prev: #13
|
4.1 | 65,000 | 118.2% |
P
S
|
120,000 | $14,986,800 | 2015 Q3 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
NVO
NOVO-NORDISK A ...
|
Healthcare | 3.96% | — |
#4
Prev: #—
|
3.6 | 110,000 | no change |
NEW
|
110,000 | $13,097,700 | 2024 Q3 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
BPMC
BLUEPRINT MEDIC...
|
Unknown | 3.91% | 1.35% |
#5
24
Prev: #29
|
3.9 | 100,000 | 250.0% |
P
S
|
140,000 | $12,950,000 | 2017 Q1 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 3.66% | 3.78% |
#6
Prev: #6
|
1.5 | -15,000 | -10.0% |
P
S
|
135,000 | $12,132,450 | 2019 Q1 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 3.48% | 2.00% |
#7
12
Prev: #19
|
3.5 | 115,000 | 48.9% |
P
S
|
350,000 | $11,511,500 | 2021 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
CATX
PERSPECTIVE THE...
|
Healthcare | 3.02% | 2.89% |
#8
3
Prev: #11
|
1.3 | -175,000 | -18.9% |
P
S
|
750,000 | $10,012,500 | 2024 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 2.85% | 2.57% |
#9
5
Prev: #14
|
1.2 | -10,000 | -3.8% |
P
S
|
250,000 | $9,432,500 | 2024 Q1 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 2.79% | 3.31% |
#10
Prev: #10
|
1.2 | -200,000 | -20.0% |
P
S
|
800,000 | $9,232,000 | 2023 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 2.76% | 3.55% |
#11
3
Prev: #8
|
1.2 | -70,000 | -46.7% |
P
S
|
80,000 | $9,141,600 | 2021 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 2.68% | 1.58% |
#12
14
Prev: #26
|
3.2 | 45,000 | 47.4% |
P
S
|
140,000 | $8,863,400 | 2022 Q4 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 2.62% | 2.25% |
#13
4
Prev: #17
|
3.1 | 100,000 | 28.6% |
P
S
|
450,000 | $8,662,500 | 2017 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
JANX
JANUX THERAPEUT...
|
Healthcare | 2.61% | 0.66% |
#14
28
Prev: #42
|
3.3 | 140,000 | 280.0% |
P
S
|
190,000 | $8,631,700 | 2024 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 2.37% | 3.70% |
#15
8
Prev: #7
|
1.1 | -34,221 | -39.5% |
P
S
|
52,500 | $7,838,775 | 2015 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 2.32% | 3.37% |
#16
7
Prev: #9
|
1.0 | -90,000 | -37.5% |
P
S
|
150,000 | $7,665,000 | 2021 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 2.29% | 3.83% |
#17
12
Prev: #5
|
1.1 | -150,000 | -50.0% |
P
S
|
150,000 | $7,573,500 | 2023 Q4 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
TGTX
TG THERAPEUTICS...
|
Healthcare | 2.19% | 2.79% |
#18
6
Prev: #12
|
1.0 | -190,000 | -38.0% |
P
S
|
310,000 | $7,250,900 | 2018 Q1 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
RZLT
REZOLUTE INC
|
Healthcare | 2.16% | 1.91% |
#19
2
Prev: #21
|
2.9 | 53,494 | 3.8% |
P
S
|
1,474,995 | $7,153,726 | 2024 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
PHAT
PHATHOM PHARMAC...
|
Healthcare | 2.05% | 1.94% |
#20
Prev: #20
|
0.9 | -225,000 | -37.5% |
P
S
|
375,000 | $6,780,000 | 2023 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 1.96% | 4.13% |
#21
17
Prev: #4
|
1.0 | -171,589 | -57.2% |
P
S
|
128,411 | $6,474,483 | 2022 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 1.93% | 1.86% |
#22
Prev: #22
|
0.8 | -15,000 | -2.7% |
P
S
|
535,000 | $6,387,900 | 2024 Q1 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 1.85% | 2.15% |
#23
5
Prev: #18
|
0.8 | -45,000 | -17.3% |
P
S
|
215,000 | $6,129,650 | 2019 Q4 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
INSM
INSMED INC
|
Healthcare | 1.65% | 1.36% |
#24
4
Prev: #28
|
2.7 | 10,000 | 15.4% |
P
S
|
75,000 | $5,475,000 | 2013 Q4 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.57% | — |
#25
Prev: #—
|
2.6 | 195,000 | no change |
NEW
|
195,000 | $5,204,550 | 2024 Q3 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 0.00% | 5.33% |
Sold All 😨
(Was: #1) |
0.3 | -490,000 | -100.0% |
CLOSED
|
— | $— | 2017 Q4 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
ALNY
PUT
ALNYLAM PHARMAC...
|
PUT Option | 0.00% | 5.20% |
Sold All 😨
(Was: #2) |
0.3 | -68,400 | -100.0% |
CLOSED
|
— | $— | 2014 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 0.00% | 1.71% |
Sold All 😨
(Was: #24) |
0.3 | -22,500 | -100.0% |
CLOSED
|
— | $— | 2014 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 0.00% | 1.14% |
Sold All 😨
(Was: #34) |
0.3 | -225,000 | -100.0% |
CLOSED
|
— | $— | 2016 Q1 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
CABA
CABALETTA BIO I...
|
Healthcare | 0.00% | 0.87% |
Sold All 😨
(Was: #40) |
0.3 | -370,899 | -100.0% |
CLOSED
|
— | $— | 2021 Q3 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 0.00% | 0.56% |
Sold All 😨
(Was: #45) |
0.3 | -33,200 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
ELEV
ELEVATION ONCOL...
|
Unknown | 0.00% | 0.51% |
Sold All 😨
(Was: #46) |
0.3 | -600,000 | -100.0% |
CLOSED
|
— | $— | 2021 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 0.00% | 0.49% |
Sold All 😨
(Was: #47) |
0.3 | -8,500 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
ANNX
CALL
ANNEXON INC
|
CALL Option | 0.00% | 0.33% |
Sold All 😨
(Was: #51) |
0.3 | -214,500 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #52) |
0.3 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
RAPT
CALL
RAPT THERAPEUTI...
|
CALL Option | 0.00% | 0.29% |
Sold All 😨
(Was: #53) |
0.3 | -300,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q3 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 0.00% | 0.28% |
Sold All 😨
(Was: #54) |
0.3 | -35,000 | -100.0% |
CLOSED
|
— | $— | 2013 Q4 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
SGMT
SAGIMET BIOSCIE...
|
Healthcare | 0.00% | 0.24% |
Sold All 😨
(Was: #55) |
0.3 | -225,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
ITCI
INTRA-CELLULAR ...
|
Unknown | 0.00% | 0.21% |
Sold All 😨
(Was: #56) |
0.3 | -10,000 | -100.0% |
CLOSED
|
— | $— | 2016 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
MGNX
MACROGENICS INC
|
Healthcare | 0.00% | 0.20% |
Sold All 😨
(Was: #57) |
0.3 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
PMVP
PMV PHARMACEUTI...
|
Healthcare | 0.00% | 0.19% |
Sold All 😨
(Was: #58) |
0.3 | -375,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 0.00% | 0.18% |
Sold All 😨
(Was: #59) |
0.3 | -19,000 | -100.0% |
CLOSED
|
— | $— | 2014 Q3 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
RVNC
REVANCE THERAPE...
|
Unknown | 0.00% | 0.18% |
Sold All 😨
(Was: #60) |
0.3 | -225,000 | -100.0% |
CLOSED
|
— | $— | 2014 Q1 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
NTLA
INTELLIA THERAP...
|
Healthcare | 0.00% | 0.18% |
Sold All 😨
(Was: #61) |
0.3 | -25,000 | -100.0% |
CLOSED
|
— | $— | 2017 Q4 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
ANTX
AN2 THERAPEUTIC...
|
Healthcare | 0.00% | 0.15% |
Sold All 😨
(Was: #62) |
0.3 | -219,331 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.00% | 0.11% |
Sold All 😨
(Was: #63) |
0.3 | -300,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2024-09-30 | 2024-11-14 (Est.) |
Showing 1-25 of 75 holdings